<html>
<head>PUBMED IDs for JM21</head>
<body bgcolor='#C5F0F2'><h1>JM21</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9683290/'>Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.</a> July 31  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10357561/'>Promising new developments in cancer chemotherapy.</a> June 5  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10393840/'>Genomic imbalances associated with acquired resistance to platinum analogues.</a> July 8  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10604725/'>Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10604718/'>Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer.</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10604712/'>CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia.</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10604662/'>p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors.</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10626362/'>Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.</a> January 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/14534679/'>Cisplatin and platinum drugs at the molecular level. (Review).</a> October 10  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/17466278/'>Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.</a> May 1  2007<br></body></html>
